Get the Stockscreener App
1.49
2.61%
-0.04
After Hours:
1.45
-0.04
-2.68%
Synlogic Inc stock is traded at $1.49, with a volume of 9,783.
It is down -2.61% in the last 24 hours and up +0.68% over the past month.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
See More
Previous Close:
$1.53
Open:
$1.445
24h Volume:
9,783
Relative Volume:
0.87
Market Cap:
$17.43M
Revenue:
$3.37M
Net Income/Loss:
$-57.28M
P/E Ratio:
-0.108
EPS:
-13.8
Net Cash Flow:
$-51.83M
1W Performance:
-4.18%
1M Performance:
+0.68%
6M Performance:
-16.76%
1Y Performance:
-46.98%
1-Day Range:
$1.41
$1.49
1-Week Range:
$1.41
$1.57
52-Week Range:
$1.22
$5.1181
Synlogic Inc Stock (SYBX) Company Profile
Name
Synlogic Inc
Sector
Industry
Phone
617-401-9975
Address
PO BOX 30, WINCHESTER, MA
Synlogic Inc Stock (SYBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-21-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-30-19 | Initiated | Jefferies | Buy |
| Dec-13-18 | Initiated | Chardan Capital Markets | Buy |
| Mar-19-18 | Initiated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Piper Jaffray | Overweight |
View All
Synlogic Inc Stock (SYBX) Latest News
Smartsheet to go private in $8.4 bln deal with PE firms Vista and Blackstone - Reuters
SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) Stock Holdings Increased by Progeny 3 Inc. - Defense World
SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) Shares Sold by Shapiro Capital Management LLC - Defense World
Smartsheet to Be Bought in $8.4 Billion Deal. The Stock Is Rising. - Barron's
21,806 Shares in Synaptics Incorporated (NASDAQ:SYNA) Bought by Intech Investment Management LLC - Defense World
Synchronoss Technologies (NASDAQ:SNCR) Shares Cross Above 200-Day Moving Average of $9.72 - Defense World
Syntara Limited Director Boosts Stake - TipRanks
SNBL and SBI Holdings Launch $40M Startup Fund - TipRanks
Smartsheet Is a Smart Buy for Traders and Investors: Here's Why - Benzinga
Where are the Opportunities in (SNCRL) - Stock Traders Daily
STRM’s Debt-to-Equity Ratio at 0.78: What It Means for Streamline Health Solutions, Inc’s Future - The InvestChronicle
Canada Pension Plan Investment Board Acquires 509,700 Shares of Symbotic Inc. (NASDAQ:SYM) - MarketBeat
Gut Microbiota Market Big Changes to Have Big Impact | Ferring, Synlogic - Newstrail
Synlogic (FRA:MIN) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
Synlogic (FRA:MIN) Volatility : 59.76% (As of Aug. 15, 2024) - GuruFocus.com
Q3 2024 EPS Estimates for Synlogic, Inc. Boosted by Analyst (NASDAQ:SYBX) - Defense World
Synlogic, Inc. (NASDAQ:SYBX) Sees Large Growth in Short Interest - Defense World
Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewswire
Synlogic Reports Second Quarter 2024 Financial Results - StockTitan
Synlogic (NASDAQ:SYBX) Stock Passes Above 50-Day Moving Average of $1.57 - Defense World
Synlogic Inc expected to post a loss of 51 cents a shareEarnings Preview - XM
Synlogic, Inc. (NASDAQ:SYBX) Short Interest Up 22.0% in July - Defense World
Synlogic (NASDAQ:SYBX) Stock Crosses Above Fifty Day Moving Average of $1.57 - Defense World
Synlogic (NASDAQ:SYBX) Shares Cross Above 50-Day Moving Average of $1.58 - Defense World
Synlogic (NASDAQ:SYBX) Stock Price Crosses Below 50 Day Moving Average of $1.61 - Defense World
Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer - Quantisnow
Synlogic Reports Second Quarter 2018 Financial Results and Provides Program Updates - br.ADVFN.com
What Makes Synlogic, Inc. (SYBX) a New Buy Stock - Yahoo New Zealand News
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks - Quantisnow
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors - StockTitan
Why Synlogic (SYBX) Could Be a Potential Winner - Yahoo Singapore News
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia
Synlogic (NASDAQ:SYBX) Share Price Crosses Below 50 Day Moving Average of $1.76 - Defense World
Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership ... - br.ADVFN.com
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Singapore News
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Movies UK
The Summer Stock Exodus: 3 Companies to Ditch Before the Heat Hits - Markets Insider
The Summer Stock Exodus: 3 Companies to Ditch Before the Heat Hits - InvestorPlace
Synlogic Announces Termination Of Abbvie Collaboration Agreement - Reuters
Leerink Partnrs Analysts Increase Earnings Estimates for Synlogic, Inc. (NASDAQ:SYBX) - Defense World
Synlogic, Inc. (SYBX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia
Synlogic Flat On Q1 Numbers - MENAFN.COM
Synlogic Flat on Q1 Numbers - Baystreet.ca
Synlogic Reports First Quarter 2024 Financial Results - ForexTV.com
Synlogic Reports First Quarter 2024 Financial Results - GlobeNewswire
Synlogic Reports First Quarter 2024 Financial Results - GlobeNewswire Inc.
Synlogic Inc expected to post a loss of 82 cents a shareEarnings Preview - XM
Will Synlogic Continue to Surge Higher? - Yahoo Lifestyle UK
Synlogic's head of finance sells shares worth $325 By Investing.com - Investing.com
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire
Synlogic Inc Stock (SYBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):